iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionShulman DeMeo Asset Management LLC
Latest Disclosed Ownership7,248 shares
Latest Disclosed Value $ 1,223,859
Shulman DeMeo Asset Management LLC reports 0.74% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 9, 2026 - Shulman DeMeo Asset Management LLC filed a 13F-HR form disclosing ownership of 7,248 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $1,223,859 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 14, 2026 disclosing 7,302 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -0.74% during the quarter. The current value of the position is $949,850 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-09 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 7,248 -54 -0.74 1,224 -0.73 0.2599
2026-01-14 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 7,302 -29 -0.40 1,232 16.45 0.2795
2025-10-17 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 7,331 -31 -0.42 1,058 13.64 0.2433
2025-07-15 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 7,362 -24 -0.32 931 -1.38 0.2306
2025-04-09 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 7,386 -20 -0.27 945 -3.58 0.2653
2025-01-15 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 7,406 -28 -0.38 979 -9.52 0.2642
2024-10-15 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 7,434 0 0.00 1,082 6.08 0.2656
2024-07-17 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 7,434 0 0.00 1,020 0.00 0.2665
2024-04-16 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 7,434 0 0.00 1,020 1.09 0.2702
2024-01-11 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 7,434 1 0.01 1,010 11.12 0.2864
2023-10-19 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 7,433 -222 -2.90 909 -6.49 0.3036
2023-07-27 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 7,655 -2 -0.03 972 -1.72 0.2907
2023-04-14 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 7,657 1 0.01 989 -1.69 0.3106
2023-01-24 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 7,656 3 0.04 1,005 12.29 0.3343
2022-10-18 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 7,653 -1,169 -13.25 895 -13.78 0.3177
2022-07-22 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 8,822 -1,310 -12.93 1,038 -21.36 0.3432
2022-04-27 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,132 3 0.03 1,320 -14.62 0.3656
2022-01-28 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 10,129 3 0.03 1,546 -5.56 0.4029
2021-10-26 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 10,126 10,126 1,637 1.4204
2021-07-21 2021-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -10,123 -100.00 0 -100.00
2021-04-26 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 10,123 65 0.65 1,524 0.00 0.4155
2021-01-13 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 10,058 668 7.11 1,524 19.81 0.4347
2020-11-02 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 9,390 1 0.01 1,272 -0.86 0.4250
2020-07-21 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 9,389 3 0.03 1,283 26.90 0.4963
2020-04-10 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 9,386 0 0.00 1,011 -10.61 0.4706
2020-01-15 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 9,386 -358 -3.67 1,131 16.60 0.3923
2019-10-30 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 9,744 0 0.00 970 -8.75 0.3252
2019-07-18 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 9,744 2 0.02 1,063 -2.39 0.3917
2019-05-01 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 9,742 9,742 1,089 0.4145
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.